As Anthropic meets with prospective investors ahead of its potentially historic market debut, CEO Dario Amodei is pushing for a slowdown in AI.

Anthropic is still likely to go public in 2026, even as AI safety rockets into the zeitgeist, multiple sources tell Axios. The big picture: A lot has changed in AI land since last week, but the IPO calendar isn't one of them.

The Claude maker has selected Nasdaq for a potential listing and could seek to raise as much as $100 billion, while its annualized revenue has surged above $65 billion and adjusted operating income is expected to remain positive for a second consecutive quarter.

Anthropic’s path to what would rank as one of the largest technology IPOs ever collided this week with a very old problem: what a company can and cannot say about its own product once it enters the SEC’s formal review window.

Electra Therapeutics is hoping to raise up to $341.9 million in a surge of IPO funding to power the clinical development of its inflammatory disorder drug ipsoprubart. | Electra Therapeutics is hoping to raise up to $341.

Etihad Airways Chief Executive Officer Antonoaldo Neves discusses fuel price hedging and the risks around the conflict in the Middle East. He also talks about a possible future IPO, saying the airline doesn't have any plans for that.

Tata Group holding company faces mounting pressure to go public as the RBI rejects its plea to surrender its Core Investment Company registration